Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2350 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Poniard Pharmaceuticals reduces workforce by 12%

The company has also announced that it will concentrate its cash resources on the clinical and commercial development of its late-stage oncology candidate, picoplatin. The company continues to